{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T05:45:34Z","timestamp":1791956734704,"version":"4.3.4"},"reference-count":33,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T00:00:00Z","timestamp":1752969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Am J Rhinol\ufffdAllergy"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Allergic rhinitis (AR) affects millions of people worldwide, impacting quality of life and causing economic burden. Intranasal corticosteroids (INCs) are the mainstay treatment for AR, delivered via aerosol or aqueous sprays.\n                    <jats:bold>Objective:<\/jats:bold>\n                    This systematic review and meta-analysis investigate the comparative efficacy and safety of aerosol and aqueous delivery methods in AR treatment.\n                    <jats:bold>Methods:<\/jats:bold>\n                    Two independent reviewers searched 4 databases (Embrace, Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, and Web of Science) for English-language, prospective randomized controlled trial (RCT), comparing aqueous and aerosol INCs for AR treatment. Studies were excluded for specific reasons (wrong comparisons, full text unavailable, insufficient data for extraction, wrong patient population, incorrect route of administration (non-intranasal), unverifiable inclusion criteria). Primary outcomes were Total Nasal Symptom Score (TNSS) and subset scores; secondary outcome was adverse event (AEs).\n                    <jats:bold>Results:<\/jats:bold>\n                    No significant difference in overall TNSS was found between the delivery methods. However, aqueous sprays showed a slight edge in reducing specific symptoms like congestion, itching, sneezing, and rhinorrhea. AEs did not differ significantly.\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    Our findings suggest no significant difference in efficacy or safety between aerosol and aqueous INCs for AR treatment. Patient preference should be a primary consideration when choosing a delivery method to optimize adherence and symptom control.\n                  <\/jats:p>","DOI":"10.1177\/19458924251360917","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T05:06:16Z","timestamp":1753074376000},"page":"444-452","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Aqueous Versus Aerosol Intranasal Corticosteroid Spray for Allergic Rhinitis: Systematic Review and Meta-Analysis"],"prefix":"10.1177","volume":"39","author":[{"given":"Dylan A.","family":"Levy","sequence":"first","affiliation":[{"name":"Tulane University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9046-5498","authenticated-orcid":false,"given":"Ajibola B.","family":"Bakare","sequence":"additional","affiliation":[{"name":"Tulane University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Gurevich","sequence":"additional","affiliation":[{"name":"Tulane University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward D.","family":"McCoul","sequence":"additional","affiliation":[{"name":"Tulane University School of Medicine"},{"name":"Department of Otorhinolaryngology, Ochsner Health, New Orleans, LA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,7,20]]},"reference":[{"issue":"2","key":"e_1_3_3_2_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2008.06.003","article-title":"The diagnosis and management of rhinitis: an updated practice parameter","volume":"122","author":"Wallace DV","year":"2008","unstructured":"Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008;122(2 Suppl):S1\u201384.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"e_1_3_3_3_2","doi-asserted-by":"crossref","DOI":"10.1067\/mai.2001.115569","article-title":"Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis","volume":"108","author":"Skoner DP","year":"2001","unstructured":"Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol. 2001;108(1 Suppl):S2\u2013S8.","journal-title":"J Allergy Clin Immunol"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-002-0023-0"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.660083"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.2500\/ajr.2007.21.2896"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200161110-00004"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.317.7173.1624"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)62085-6"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.08.049"},{"issue":"1","key":"e_1_3_3_11_2","article-title":"Clinical practice guideline: allergic rhinitis","volume":"152","author":"Seidman MD","year":"2015","unstructured":"Seidman MD, Gurgel RK, SY L, et al. Clinical practice guideline: allergic rhinitis. Otolaryngol Head Neck Surg. 2015;152(1 Suppl):S1\u201343.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"e_1_3_3_12_2","article-title":"The history and progression of treatments for allergic rhinitis","volume":"35","author":"Ostrom NK","year":"2014","unstructured":"Ostrom NK. The history and progression of treatments for allergic rhinitis. Allergy Asthma Proc. 2014;35(Suppl 1):S3\u201310.","journal-title":"Allergy Asthma Proc"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.2500\/ajra.2013.27.3946"},{"issue":"1","key":"e_1_3_3_14_2","first-page":"23","article-title":"Comparison of once-daily intranasal corticosteroids for the treatment of allergic rhinitis: are they all the same?","volume":"8","author":"Yawn B","year":"2006","unstructured":"Yawn B. Comparison of once-daily intranasal corticosteroids for the treatment of allergic rhinitis: are they all the same? MedGenMed. 2006;8(1):23.","journal-title":"MedGenMed"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2013.34.3705"},{"issue":"4","key":"e_1_3_3_16_2","first-page":"205","article-title":"Flunisolide nasal spray compared to beclomethasone dipropionate in the treatment of seasonal rhinitis","volume":"20","author":"Aasand G","year":"1982","unstructured":"Aasand G, Etholm BO, Skjostad M, Volden J. Flunisolide nasal spray compared to beclomethasone dipropionate in the treatment of seasonal rhinitis. Rhinology. 1982;20(4):205\u2013211.","journal-title":"Rhinology"},{"issue":"4","key":"e_1_3_3_17_2","first-page":"287","article-title":"A double-blind study comparing two nasal sprays of beclomethasone dipropionate in the management of seasonal rhinitis","volume":"10","author":"Baggott PJ","year":"1984","unstructured":"Baggott PJ, Dash CH, Haydock A, Pover GM, Sidwell S. A double-blind study comparing two nasal sprays of beclomethasone dipropionate in the management of seasonal rhinitis. Drugs Exp Clin Res. 1984;10(4):287\u2013292.","journal-title":"Drugs Exp Clin Res"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.2500\/105065897781446847"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.60.704.404"},{"issue":"9","key":"e_1_3_3_20_2","first-page":"623","article-title":"A comparison of an aqueous and a pressurized nasal spray of beclomethasone dipropionate in the management of seasonal rhinitis","volume":"3","author":"Harries MG","year":"1984","unstructured":"Harries MG, Anderson PB, Gibson GJ, Hof ZE, Baggott PJ. A comparison of an aqueous and a pressurized nasal spray of beclomethasone dipropionate in the management of seasonal rhinitis. Pharmatherapeutica. 1984;3(9):623\u2013625.","journal-title":"Pharmatherapeutica"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2273.1984.tb01503.x"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(86)90384-2"},{"issue":"3","key":"e_1_3_3_23_2","first-page":"183","article-title":"A comparative trial testing budesonide and flunisolide nasal sprays in patients with seasonal allergic rhinitis","volume":"52","author":"Pipkorn U","year":"1984","unstructured":"Pipkorn U, Geterud A. A comparative trial testing budesonide and flunisolide nasal sprays in patients with seasonal allergic rhinitis. Ann Allergy. 1984;52(3 Pt 1):183\u2013186.","journal-title":"Ann Allergy"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.2500\/105065898780707991"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1980.tb02081.x"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007998309109815"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1983.tb04123.x"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(97)70160-X"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2012.33.3593"},{"issue":"2","key":"e_1_3_3_30_2","article-title":"Insights on allergic rhinitis from the patient perspective","volume":"61","author":"Fromer LM","year":"2012","unstructured":"Fromer LM, Ortiz G, Ryan SF, Stoloff SW. Insights on allergic rhinitis from the patient perspective. J Fam Pract. 2012;61(2 Suppl):S16\u2013S22.","journal-title":"J Fam Pract"},{"issue":"1","key":"e_1_3_3_31_2","article-title":"Patient and physician perspectives on the attributes of nasal allergy medications","volume":"28","author":"Naclerio RM","year":"2007","unstructured":"Naclerio RM, Hadley JA, Stoloff S, Nelson HS. Patient and physician perspectives on the attributes of nasal allergy medications. Allergy Asthma Proc. 2007;28(Suppl 1):S11\u2013S17.","journal-title":"Allergy Asthma Proc"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2014.1180"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.2500\/ajra.2014.28.4026"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2011.32.3438"}],"container-title":["American Journal of Rhinology &amp; Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19458924251360917","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/19458924251360917","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19458924251360917","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:55:53Z","timestamp":1791953753000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/19458924251360917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,20]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1177\/19458924251360917"],"URL":"https:\/\/doi.org\/10.1177\/19458924251360917","relation":{},"ISSN":["1945-8924","1945-8932"],"issn-type":[{"value":"1945-8924","type":"print"},{"value":"1945-8932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,20]]}}}